Total Payments
$5,394
2024 Payments
$816.83
Companies
32
Transactions
268
Medicare Patients
2,483
Medicare Billing
$157,827
Payment Breakdown by Category
Food & Beverage$5,394 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,394 | 268 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $966.92 | 49 | $0 (2024) |
| UCB, Inc. | $603.04 | 39 | $0 (2024) |
| SK Life Science, Inc. | $398.14 | 4 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $365.29 | 15 | $0 (2022) |
| Allergan, Inc. | $338.06 | 19 | $0 (2022) |
| Biogen, Inc. | $275.69 | 13 | $0 (2023) |
| HARMONY BIOSCIENCES LLC | $273.80 | 17 | $0 (2024) |
| Scilex Pharmaceuticals Inc. | $270.61 | 13 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $249.21 | 12 | $0 (2024) |
| Azurity Pharmaceuticals, Inc. | $244.09 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $816.83 | 32 | ABBVIE INC. ($282.05) |
| 2023 | $1,852 | 94 | ABBVIE INC. ($505.54) |
| 2022 | $1,352 | 61 | Arbor Pharmaceuticals, Inc. ($201.64) |
| 2021 | $1,373 | 81 | UCB, Inc. ($334.53) |
All Payment Transactions
268 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Neuroscience | ||||||
| 04/30/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 04/25/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 04/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Neurology | ||||||
| 03/19/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 03/15/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.16 | General |
| Category: Narcoplepsy | ||||||
| 03/14/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $35.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: Narcoplepsy | ||||||
| 02/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 02/15/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Adenosine A2A Receptors | ||||||
| 02/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Neurology | ||||||
| 02/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $34.60 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Neurology | ||||||
| 02/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: PAIN | ||||||
| 02/01/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: NEUROLOGY | ||||||
| 01/31/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Neurology | ||||||
| 01/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,190 | 2,133 | $144,162 | $74,175 |
| 2022 | 9 | 597 | 1,001 | $82,671 | $35,534 |
| 2021 | 9 | 479 | 788 | $58,852 | $28,594 |
| 2020 | 7 | 217 | 494 | $31,108 | $19,523 |
Total Patients
2,483
Total Services
4,416
Medicare Billing
$157,827
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 320 | 562 | $60,239 | $38,209 | 63.4% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 150 | 343 | $15,708 | $10,072 | 64.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 60 | $9,053 | $5,613 | 62.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 18 | 18 | $4,506 | $2,992 | 66.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 18 | 36 | $4,207 | $2,792 | 66.4% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 25 | 25 | $3,882 | $2,586 | 66.6% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 28 | 28 | $3,560 | $2,364 | 66.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $2,775 | $1,842 | 66.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 83 | 156 | $2,595 | $1,695 | 65.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 57 | 106 | $1,988 | $1,298 | 65.3% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2023 | 22 | 31 | $1,687 | $1,043 | 61.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $1,754 | $1,026 | 58.5% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Office | 2023 | 28 | 28 | $1,314 | $873.96 | 66.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 15 | 17 | $1,283 | $774.61 | 60.4% |
| 92547 | Use of electrodes during balance testing | Office | 2023 | 28 | 28 | $367.90 | $288.39 | 78.4% |
| J3411 | Injection, thiamine hcl, 100 mg | Office | 2023 | 65 | 141 | $10,850 | $270.70 | 2.5% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2023 | 144 | 332 | $11,438 | $198.90 | 1.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 63 | 127 | $4,507 | $149.13 | 3.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 11 | 12 | $330.00 | $69.17 | 21.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 19 | 42 | $1,740 | $18.24 | 1.0% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 13 | 14 | $380.00 | $0.26 | 0.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 275 | 408 | $44,827 | $24,699 | 55.1% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 80 | 168 | $8,264 | $5,248 | 63.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 41 | $6,299 | $3,347 | 53.1% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2022 | 20 | 28 | $1,755 | $921.93 | 52.5% |
About Tetyana Roytman, FNP
Tetyana Roytman, FNP is a Family healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2019. The National Provider Identifier (NPI) number assigned to this provider is 1982249868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tetyana Roytman, FNP has received a total of $5,394 in payments from pharmaceutical and medical device companies, with $816.83 received in 2024. These payments were reported across 268 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,394).
As a Medicare-enrolled provider, Roytman has provided services to 2,483 Medicare beneficiaries, totaling 4,416 services with total Medicare billing of $157,827. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Brooklyn, NY
- Active Since 11/14/2019
- Last Updated 03/01/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982249868
Products in Payments
- BOTOX (Biological) $705.13
- Horizant (Drug) $513.71
- Briviact (Drug) $434.22
- XCOPRI (Drug) $374.69
- UBRELVY (Drug) $282.06
- WAKIX (Drug) $260.25
- ZTLido (Drug) $228.85
- QULIPTA (Drug) $202.15
- TYSABRI (Biological) $181.04
- Neupro (Drug) $168.82
- EMGALITY (Drug) $168.50
- RYTARY (Drug) $144.06
- INGREZZA (Drug) $138.01
- APTIOM (Drug) $126.68
- NUEDEXTA (Drug) $115.77
- ONGENTYS (Drug) $111.20
- VYEPTI (Biological) $106.21
- VUMERITY (Drug) $94.65
- VALTOCO (Drug) $94.12
- Leqembi (Drug) $92.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Brooklyn
Susan Weiss, Np, NP
Family — Payments: $20,923
Family $20,923
Ms. Abigail Hunter, Fnp, FNP
Family — Payments: $18,034
Family $18,034
Seida Velija
Family — Payments: $15,903
Family $15,903
Ami Lam
Family — Payments: $15,616
Family $15,616
Christina Lao
Family — Payments: $15,127
Family $15,127
Mrs. Kelly Morris, Fnp, FNP
Family — Payments: $8,415
Family $8,415